Related Experiment Video

Updated: Aug 4, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Effects of indomethacin on thyroid iodine metabolism

H M Targovnik, V Varela, A B Houssay

    Acta Physiologica Latino Americana
    |January 1, 1983
    PubMed

    Several alterations of thyroid function parameters have been reported in animals treated with indomethacin, and we have studied the effect of this drug on the intrathyroidal iodine metabolism in Wistar rats. Indomethacin was administered by an esophagic tube in two doses (total = 6 mg) given at 0 and 5 hours in experiment I and three doses (total = 9 mg) given at 0, 10 and 23 hours in experiment II. No significant differences in thyroid weight, thyroidal 131I uptake and (131I) iodoaminoacids distribution was observed between the controls and indomethacin treated rats in experiments I and II. In experiment II the intrathyroidal protein bound 131I was not affected by indomethacin, but the extrathyroidal protein bound 131I was markedly affected by the drug, with 72% inhibition. Thyroid peroxidase activity was scarcely affected by the action of the drug. In experiment I indomethacin produced a reduction in serum total thyroxine (T4) of 52%, with a significant elevation in serum total triiodothyronine (T3) of 37%. In experiment II the serum total T4 and T3 levels in indomethacin treated rats were significantly reduced when compared to those of the control rats (77% and 56%, respectively). Serum thyrotropin (TSH) levels did not change in any of the two experiments. In summary, we have found that administration of indomethacin to rats causes an inhibition of thyroid function, measured by decreased thyroid hormone blood levels, without any change in the iodine organification process in these glands.

    More Related Videos

    In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse04:14

    In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

    Published on: October 6, 2023

    Colorimetric Assessment of Deiodinase 1 Activity in Human Liver Microsomes Using the Sandell-Kolthoff Reaction08:00

    Colorimetric Assessment of Deiodinase 1 Activity in Human Liver Microsomes Using the Sandell-Kolthoff Reaction

    Published on: April 10, 2026

    Related Concept Videos

    Hormones and Bone Tissue01:17

    Hormones and Bone Tissue

    The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
    Hormones That Influence Osteoblasts and/or Maintain the Matrix
    Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
    Therapeutic Index01:13

    Therapeutic Index

    The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
    Redox Titration: Iodimetry and Iodometry01:23

    Redox Titration: Iodimetry and Iodometry

    Iodometry and iodimetry are analytical methods used to determine the concentration of oxidizing or reducing agents using iodine. In iodometric titrations, the oxidizing analyte solution is usually acidified and treated with an excess of iodide ions, which generates an equivalent amount of iodine in equilibrium with triiodide. The released iodine is subsequently titrated directly against a standardized reducing agent. As the dilute iodine color becomes pale yellow, a few drops of freshly...
    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

    Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

    Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
    Graves Disease II: Pathophysiology01:24

    Graves Disease II: Pathophysiology

    Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...